Cogent Biosciences, Inc. (COGT)
37.34
-1.00
(-2.61%)
USD |
NASDAQ |
Feb 20, 16:00
37.56
+0.22
(+0.59%)
After-Hours: 20:00
Cogent Biosciences SG&A Expense (Quarterly) : 23.93M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.898B |
| Sarepta Therapeutics, Inc. | 91.89M |
| Cidara Therapeutics, Inc. | 8.099M |
| BridgeBio Pharma, Inc. | 137.62M |
| Olema Pharmaceuticals, Inc. | 5.926M |